Taken together, we report LRRFIP2 as an alternative splicing target of ESRP1 in gastric cancer, which represents a regulatory mechanism of LRRFIP2 splicing variants in gastric cancer metastasis. Here, LRRFIP2 is linked to gastric cancer.